Jazz Pharmaceuticals plc will report its fourth quarter and full year 2025 financial results on February 24, 2026, after the close of U.S. financial markets. Company management will host a webcast at 4:30 p.m. ET / 9:30 p.m. GMT to discuss the results and provide a business and financial update. Results will be released via the Investors section of the Jazz Pharmaceuticals website. Interested parties may register for the call in advance at the Investors section of the Jazz Pharmaceuticals website at https://www.jazzpharmaceuticals.com. A replay of the webcast will be available at https://investor.jazzpharma.com/investors/events-presentations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via PR Newswire (Ref. ID: SF84023) on February 10, 2026, and is solely responsible for the information contained therein.